“From start to finish I’ve been impressed with Oxford’s professionalism, competence, courtesy, focus, tenacity and responsiveness. Very few organizations have impressed me as much in my 30 plus years in the business.”

James Andrews, Vice President &
Chief Financial Officer
AngioScore

 
   

"Oxford was responsive, flexible and competitively priced. Their stable financial backing makes it possible to rely on a long-term relationship. They‘re straight shooters, fair, honest and get the deal done."

David Nassif, Executive Vice President &
Chief Financial Officer
Zogenix

 
   

"Oxford was great at meeting or exceeding deliverables, and their terms were better than anyone else out there. They were honest about what could and couldn’t be done, and kept us informed throughout the lending process. The Oxford team really understood my business which made it much easier for us to achieve our financial goals."

Tina Fiumenero, Chief Financial Officer
Vitae Pharmaceuticals

 
   

"This company definitely assess risk differently from their competitors, and does a great job with their due diligence early on and throughout the relationship. Their affiliation with Sumitomo will be instrumental in our search for a partner in Japan. I would advise companies looking for debt to look at all options, but they’ll probably end up with Oxford because they are the best. "

Jason Wilson, Vice President of Finance
Reata Pharmaceuticals

 
   

"When doing business with Oxford, we were able to talk directly to the decision makers so the deal moved along quickly. They were focused on the future of our business and offered us the fairest deal in town."

Thomas Insley, Senior Vice President &
Chief Financial Officer
SkinMedica

 
   

"Oxford is great to work with, and they are more flexible than banks since they don’t have the same constraints. They really understand how biotech and healthcare companies work, and move quickly to get the deal done."

Dennis Bourgeault, Chief Financial Officer
Isotechnika

 
   

"After looking at five or six competing proposals, Oxford simply presented us with the best product, and they work hard to build and maintain relationships with their clients. I appreciated their ability to move the deal along quickly and decisively."

Kevin Nickels, President & Chief Executive Officer
Celleration